Publication | Closed Access
Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry
89
Citations
21
References
2006
Year
Die Triazolverknüpfung ErzeugtImmunologyPharmacotherapyClick ChemistryAntiviral DrugChemical BiologyMedicinal ChemistryHuman RetrovirusAntiviral Drug DevelopmentResistance Mutation (Virology)BiochemistrySchwach BindenHivPharmacologyAntiviral CompoundSitu Click ChemistryBiomolecular EngineeringNatural SciencesAntiviral TherapyIndem Sie MitMedicineDrug Discovery
Zweimal schwach gibt mächtig: Die HIV-1-Protease baut ihren eigenen leistungsfähigen Inhibitor zusammen, indem sie mit einem azid- und einem alkinhaltigen Fragment, die beide schwach binden, die Triazolverknüpfung erzeugt. Supporting information for this article is available on the WWW under http://www.wiley-vch.de/contents/jc_2001/2006/z502161_s.pdf or from the author. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
| Year | Citations | |
|---|---|---|
Page 1
Page 1